Heterotypic cell-in-cell structures between cancer and NK cells are associated with enhanced anticancer drug resistance

[1]  S. Vidyalakshmi,et al.  Study on reversal of ABCB1 mediated multidrug resistance in Colon cancer by acetogenins: An in-silico approach , 2020, Journal of biomolecular structure & dynamics.

[2]  Hui Zhang,et al.  Progress of long noncoding RNAs in anti-tumor resistance. , 2020, Pathology, research and practice.

[3]  T. Salo,et al.  Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer , 2020, BMC cancer.

[4]  Qiang Sun,et al.  Mechanical Ring Interfaces between Adherens Junction and Contractile Actomyosin to Coordinate Entotic Cell-in-Cell Formation. , 2020, Cell reports.

[5]  B. AbdullGaffar.  Emperipolesis of lymphocytes by mesothelial cells in pleural effusion involved by T‐lymphoblastic lymphoma , 2020, Diagnostic cytopathology.

[6]  C. Iacobuzio-Donahue,et al.  Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma , 2020, Modern Pathology.

[7]  C. Cho,et al.  Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer - A comprehensive review from chemotherapy to immunotherapy. , 2020, Pharmacological research.

[8]  K. Hong,et al.  A three-dimensional hyaluronic acid-based niche enhances the therapeutic efficacy of human natural killer cell-based cancer immunotherapy. , 2020, Biomaterials.

[9]  Qiang Sun,et al.  High Frequency of Cell-in-Cell Formation in Heterogeneous Human Breast Cancer Tissue in a Patient With Poor Prognosis: A Case Report and Literature Review , 2019, Front. Oncol..

[10]  Jisheng Hu,et al.  Cell-in-Cell Phenomenon and Its Relationship With Tumor Microenvironment and Tumor Progression: A Review , 2019, Front. Cell Dev. Biol..

[11]  R. Schmid,et al.  Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment , 2019, Cancer Cell International.

[12]  Neil Vasan,et al.  A view on drug resistance in cancer , 2019, Nature.

[13]  Qiang Sun,et al.  Subtype-Based Prognostic Analysis of Cell-in-Cell Structures in Early Breast Cancer , 2019, Front. Oncol..

[14]  M. Overholtzer,et al.  Cell-in-cell phenomena in cancer , 2018, Nature Reviews Cancer.

[15]  Nicolai J. Birkbak,et al.  Genomic instability in mutant p53 cancer cells upon entotic engulfment , 2018, Nature Communications.

[16]  R. Fietkau,et al.  Cell-in-cell structures are more potent predictors of outcome than senescence or apoptosis in head and neck squamous cell carcinomas , 2017, Radiation oncology.

[17]  T. Fujiwara,et al.  Tumor-specific delivery of biologics by a novel T-cell line HOZOT , 2016, Scientific Reports.

[18]  F. McCormick,et al.  Drug Resistance to EGFR Inhibitors in Lung Cancer , 2016, Chemotherapy.

[19]  Q. Sun,et al.  Mammalian Cell Competitions, Cell-in-Cell Phenomena and Their Biomedical Implications. , 2015, Current molecular medicine.

[20]  D. L. Le Couteur,et al.  Suicidal emperipolesis: a process leading to cell-in-cell structures, T cell clearance and immune homeostasis. , 2015, Current molecular medicine.

[21]  Qiang Sun,et al.  Detecting cell-in-cell structures in human tumor samples by E-cadherin/CD68/CD45 triple staining , 2015, Oncotarget.

[22]  Mei He,et al.  Prevalence of Heterotypic Tumor/Immune Cell-In-Cell Structure In Vitro and In Vivo Leading to Formation of Aneuploidy , 2013, PloS one.

[23]  G. Finocchiaro,et al.  Neutrophil-tumor cell phagocytosis (cannibalism) in human tumors: an update and literature review. , 2012, Experimental oncology.

[24]  D. Stewart.  Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. , 2010, Critical reviews in oncology/hematology.

[25]  Dong Oh Kim,et al.  Suppressor of Cytokine Signaling 2 Regulates IL-15–Primed Human NK Cell Function via Control of Phosphorylated Pyk2 , 2010, The Journal of Immunology.

[26]  S. Safe,et al.  Enhancement of Docetaxel Anticancer Activity by a Novel Diindolylmethane Compound in Human Non–Small Cell Lung Cancer , 2009, Clinical Cancer Research.

[27]  W. Foulkes.  p53--master and commander. , 2007, The New England journal of medicine.

[28]  M. Garrett,et al.  Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis , 2005, Oncogene.

[29]  M. Overholtzer,et al.  Methods for the Study of Entotic Cell Death. , 2019, Methods in molecular biology.